达格列净通过SIRT1/AMPK通路对小鼠心力衰竭改善的分子机制

Abstract
Figure/Table
References
Related Citation (9)

Download: PDF (3018 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Purpose To investigate the improvement effect of dapagliflozin with heart failure based on SIRT1/AMPK pathway. Methods Animal TAC models were developed in C57BL/6J mice and divided into sham, sham+DAPA, TAC, and TAC+DAPA groups. Gravimetric and histological analysis of organ size and weight, HE staining, WGA staining, Masson, Sirius Red staining, DHE staining and TUNEL assay to analyze histopathology, cardiomyocyte size, collagen fibers, ROS production and apoptosis, qRT- The expressions of atrial natriuretic factor (Nppa), brain natriuretic peptide (Nppb), myosin heavy chain 7(Myh7), TGF-β1 and SIRT1/AMPK signaling pathway were detected by PCR and western blotting. Results CHW/TL, HW/BW and HW/LW were significantly reduced in DAPA TAC mice compared with sham operation group. As assessed by WGA staining, the mean cross-section area of cardiocytes in TAC mice was larger. Increases in Nppa, Nppb, and Myh7, in addition to high levels of ANP and β-MHC in TAC mice, decreased mean cardiomyocyte cross-sectional area was observed in DAPA-administered TAC mice. mRNA and protein levels of markers of cardiac hypertrophy were significantly reduced. Masson and Sirius red were used to examine the degree of myocardial fibrosis. Compared with the sham operation group, the myocardial fibrosis area of TAC mice was significantly increased, the mRNA and protein levels of TGF-β1 in TAC group were increased, and the myocardial ROS levels of TAC mice were higher. TUNEL staining showed that the apoptosis rate of cardiomyocytes in TAC group was significantly increased, and the expression of SIRT1/AMPK pathway was decreased, but DAPA had the opposite effect, the difference was statistically significant. ompared with the sham-operated group, HW/TL, HW/BW and HW/LW were significantly reduced in TAC mice with DAPA, and the mean cross-sectional area of cardiomyocytes in TAC mice was large, Nppa, Nppb and Myh7 as assessed by WGA staining In addition, TAC mice had high levels of ANP and β-MHC, and a reduction in mean cardiomyocyte cross-sectional area and significantly lower mRNA and protein levels of cardiac hypertrophy markers were observed in DAPA-administered TAC mice. Masson and Sirius Red examined the degree of myocardial fibrosis. Compared with the sham-operated group, the myocardial fibrosis area of TAC mice was significantly increased, the mRNA and protein levels of TGF-β1 in the myocardium of the TAC group were increased, and the myocardial ROS level of TAC mice TUNEL staining showed that the apoptosis rate of cardiomyocytes in the TAC group was significantly increased, and the expression of SIRT1/AMPK pathway was decreased, but the effect of DAPA was the opposite, and the difference was statistically significant. Conclusion DAPA activates SIRT1/AMPK pathway signaling, thereby reducing cardiac fibrosis, hypertrophic remodeling, and myocardial oxidative stress.

Key words： mice heart failure dapagliflozin SIRT1/AMPK

Received: 24 September 2023

PACS:

R541.6

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	WU Jia
	WU Jin
	XIAO Kai
	LING Chao

Cite this article:

WU Jia,WU Jin,XIAO Kai等. The improvement effect of dapagliflozin with heart failure based on SIRT1/AMPK pathway[J]. HuNan ShiFan DaXue XueBao(YiXueBan), 2023, 20(6): 28-34.

URL:

http://yxb.hunnu.edu.cn/EN/ OR http://yxb.hunnu.edu.cn/EN/Y2023/V20/I6/28

[1] 崔文建, 吴荣, 刘野, 等. 达格列净对心力衰竭大鼠心功能和线粒体能量代谢的影响[J]. 中国临床药理学杂志, 2023, 39(09) : 1247-1251.
[2] JENČA D, MELENOVSKÝ V, STEHLIK J, et al. Heart failure after myocardial infarction: incidence and predictors[J]. ESC Heart Fail, 2021, 8(1) : 222-223.
[3] CECH TR, STEITZ JA.The noncoding RNA revolution-trashing old rules to forge new ones[J]. Cell, 2014, 157(1) : 77-78.
[4] D'ONOFRIO N, SERVILLO L, BALESTRIERI ML. SIRT1 and SIRT6 signaling pathways in cardiovascular disease protection[J]. Antioxid Redox Signal, 2018, 28(8) : 711-713.
[5] ALCENDOR RR, GAO S, ZHAI P, et al.Sirt1 regulates aging and resistance to oxidative stress in the heart[J]. Circ Res, 2007, 100(10) : 1512-1514.
[6] WANG B, NIE J, WU L, HU Y, et al.AMPKα2 protects against the development of heart failure by enhancing mitophagy via PINK1 phosphorylation[J]. Circ Res, 2018, 122(5) : 712-713.
[7] PRICE N.L, GOMES AP, LING AJ, et al. SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function[J]. Cell Metab, 2012, 15(5) : 675-677.
[8] REN FF, XIE ZY, JIANG YN, et al.Dapagliflozin attenuates pressure overload-induced myocardial remodeling in mice via activating SIRT1 and inhibiting endoplasmic reticulum stress[J]. Acta Pharmacol Sin, 2022, 43(7) : 1721-1724.
[9] 杨薪, 蔡学坤, 吴泽龙, 等. 达格列净对慢性心力衰竭大鼠心肌细胞基质金属蛋白酶及其组织抑制因子-1水平的影响[J]. 中国临床药理学杂志, 2023, 39(08) : 1104-1107.
[10] KAPLINSKY E.DAPA-HF trial: dapagliflozin evolves from a glucose-lowering agent to a therapy for heart failure[J]. Drugs Context, 2020, 9: 11-12.
[11] LI J, JIA L, HAO Z, et al.Site-specific N-glycoproteomic analysis reveals upregulated sialylation and core fucosylation during transient regeneration loss in neonatal mouse hearts[J]. J Proteome Res, 2020, 19(8) : 3191-3193.
[12] 何智余. SGLT2抑制剂通过调控自噬改善心脏重塑的作用及机制研究[D]. 兰州: 兰州大学, 2023.
[13] ZHANG L, HE J, WANG J, et al.Knockout RAGE alleviates cardiac fibrosis through repressing endothelial-to-mesenchymal transition (EndMT) mediated by autophagy[J]. Cell Death Dis, 2021, 12(5) : 470-471.
[14] WIDYANTORO B, EMOTO N, NAKAYAMA K.Endothelial cell‐derived endothelin‐1 promotes cardiac fibrosis in diabetic hearts through stimulation of endothelial‐to‐mesenchymal transition[J]. Circulation, 2010, 121(22) : 2407-2408.
[15] GOH K.Y, HE L, SONG J. Mitoquinone ameliorates pressure overload-induced cardiac fibrosis and left ventricular dysfunction in mice[J]. Redox Biol, 2019, 21: 101100-101101.
[16] MORCIANO G, PATERGNANI S, BONORA M.Mitophagy in cardiovascular diseases[J]. Clin Med, 2020, 9(3) : 892-894.
[17] MORALES P.E, ARIAS-DURÁN C, ÁVALOS-GUAJARDO Y. Emerging role of mitophagy in cardiovascular physiology and pathology[J]. Aspect Med, 2020, 71: 100822-10823.
[18] JIANG L, YIN X, CHEN YH, et al.Proteomic analysis reveals ginsenoside Rb1 attenuates myocardial ischemia/reperfusion injury through inhibiting ROS production from mitochondrial complex I[J]. Theranostics, 2021, 11(4) : 1703-1704.
[19] GU M, WANG J, WANG Y, et al.MiR-147b inhibits cell viability and promotes apoptosis of rat H9c2 cardiomyocytes via down-regulating KLF13 expression[J]. Acta Biochim Biophys Sin, 2018, 50(3) : 288-289.
[20] PROLA A, PIRES DA SILVA J, GUILBERT A, et al. SIRT1 protects the heart from ER stress-induced cell death through eIF2α deacetylation[J]. Cell Death Differ, 2017, 24(2) : 343-345.
[21] CHEN X, ZHANG X, GROSS S, et al.Acetylation of SERCA2a, another target for heart failure treatment[J]. Circ Res, 2019, 124(9) : 1285-1288.
[22] DIOUM EM, CHEN R, ALEXANDER MS, et al.Regulation of hypoxia-inducible factor 2alpha signaling by the stress-responsive deacetylase sirtuin 1[J]. Science, 2009, 324(5932) : 1289-1290.
[23] 孙云静, 王林青, 张亚静, 等. 基于P38 MAPK信号通路探讨达格列净对老年2型糖尿病伴慢性心力衰竭患者心功能、主要心血管不良事件发生风险的影响[J]. 中国糖尿病杂志, 2022, 30(07) : 501-506.